Glenmede Trust’s Genomic Health, Inc. GHDX Stock Holding History

Glenmede Trust’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,107	Closed	-$74	–	3215
2019 Q3	$74	Buy	1,107 +107	+11%	+$7.35K	﹤0.01%	1505
2019 Q2	$58	Sell	1,000 -168	-14%	-$9.95K	﹤0.01%	1610
2019 Q1	$81	Hold	1,168	–	–	﹤0.01%	1473
2018 Q4	$74	Buy	+1,168	New	+$81.9K	﹤0.01%	1438
2018 Q3	–	Sell	-1,000	Closed	-$50K	–	1957
2018 Q2	$50K	Hold	1,000	–	–	﹤0.01%	1450
2018 Q1	$34K	Hold	1,000	–	–	﹤0.01%	1776
2017 Q4	$34K	Hold	1,000	–	–	﹤0.01%	1776
2017 Q3	$32K	Hold	1,000	–	–	﹤0.01%	1814
2017 Q2	$31K	Hold	1,000	–	–	﹤0.01%	1775
2017 Q1	$31K	Hold	1,000	–	–	﹤0.01%	1775
2016 Q4	$29K	Hold	1,000	–	–	﹤0.01%	1786
2016 Q3	$28K	Sell	1,000 -46	-4%	-$1.28K	﹤0.01%	1829
2016 Q2	$26K	Sell	1,046 -58	-5%	-$1.54K	﹤0.01%	1811
2016 Q1	$26K	Buy	1,104 +46	+4%	+$1.26K	﹤0.01%	1731
2015 Q4	$37K	Buy	1,058 +1,000	+1,724%	+$26.8K	﹤0.01%	1668
2015 Q3	$1K	Buy	+58	New	+$1.5K	﹤0.01%	2652

Glenmede Trust's GHDX Position: Q4 2019 in Review

Glenmede Trust sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 1,107 shares — an estimated $74 sold.

Glenmede Trust first reported a position in GHDX in Q3 2015 and held it in 16 quarters. The position peaked at $50K in Q2 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Glenmede Trust reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Glenmede Trust sold 1,107 Genomic Health, Inc. shares in Q4 2019, an estimated $74.
Glenmede Trust first reported a position in Genomic Health, Inc. in Q3 2015 and held it in 16 quarters.
Glenmede Trust's Genomic Health, Inc. position peaked at $50K in Q2 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.